- Series: Encyclopedia of Psychoactive Drugs Series II
- Library Binding: 109 pages
- Publisher: Chelsea House Pub (L) (February 1987)
- Language: English
- ISBN-10: 155546209X
- ISBN-13: 978-1555462093
- Product Dimensions: 0.5 x 6.8 x 9.5 inches
- Shipping Weight: 13.6 ounces
- Average Customer Review: 3.9 out of 5 stars See all reviews (7 customer reviews)
- Amazon Best Sellers Rank: #5,521,226 in Books (See Top 100 in Books)
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter your mobile phone number.
Drugs and the Brain (Encyclopedia of Psychoactive Drugs Series II)
Use the Amazon App to scan ISBNs and compare prices.
Featured resources for clinical rotations
Explore these titles for clinical rotations. Learn more
Customers who viewed this item also viewed
What other items do customers buy after viewing this item?
From Library Journal
This 1986 volume details how drugs affect brain functions and their use in the fight against anxiety, mental illness, etc.
Copyright 1996 Reed Business Information, Inc. --This text refers to an out of print or unavailable edition of this title.
If you are a seller for this product, would you like to suggest updates through seller support?
Top Customer Reviews
Dr. Snyder runs through the litany of the common classes of drugs: the opiates and their natural countersubstance, the endorphins--the stimulants and their action of dopamine reuptake blockage--the hallucinogens and their concomitant serotonergic pathways--and some of the more popular psychopharmcologicals specific to schizophrenia, depression, and anxiety.
This book is a well written, historically informative, crash course in pharmacology for the lay reader, and remains a valuable reference long after its initial reading.
Subjects touched upon include the use of drugs in religious ceremony, Freud's cocain habit, the 60s, and the modern era of specialized mood-altering drugs.
The author is chair of Neuroscience at Johns Hopkins University in Baltimore, Maryland and one of the top three most cited scientists in the life science.
It is a pleasure to read, and a springboard for further investigation in the areas of psychopharmacology, neuroscience or psychiatry.